Detalhe da pesquisa
1.
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced Therapies.
Clin Gastroenterol Hepatol
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723981
2.
ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.
Clin Gastroenterol Hepatol
; 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951560
3.
Supratherapeutic Infliximab Levels Do Not Predict Risk of Short-term Complications in Adults With Crohn's Disease.
J Clin Gastroenterol
; 57(1): 66-73, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907922
4.
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 20(1): 116-125.e5, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33039585
5.
Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis.
Am J Gastroenterol
; 116(5): 1007-1014, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33929379
6.
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
Am J Gastroenterol
; 116(10): 2014-2025, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388143
7.
Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.
Clin Gastroenterol Hepatol
; 18(10): 2262-2268, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31683056
8.
Self-help Cognitive Behavioral Therapy Improves Health-Related Quality of Life for Inflammatory Bowel Disease Patients: A Randomized Controlled Effectiveness Trial.
J Clin Psychol Med Settings
; 27(3): 467-479, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025253
9.
Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.
Gastroenterology
; 155(4): 1098-1108.e9, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29964043
10.
Market Access Analysis of Biologics and Small-Molecule Inhibitors for Inflammatory Bowel Disease Among US Health Insurance Policies.
Dig Dis Sci
; 64(9): 2478-2488, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923985
11.
Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease.
Am J Gastroenterol
; 113(3): 405-417, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29336432
12.
Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease.
Dig Dis Sci
; 63(3): 761-767, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29340807
13.
Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab.
Clin Gastroenterol Hepatol
; 15(10): 1580-1588.e3, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28365486
14.
Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab.
Am J Gastroenterol
; 111(12): 1806-1815, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27670599
15.
Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.
Ann Rheum Dis
; 75(10): 1813-8, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26792814
16.
Mortality associated with medical therapy versus elective colectomy in ulcerative colitis: a cohort study.
Ann Intern Med
; 163(4): 262-70, 2015 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26168366
17.
Effectiveness and Safety of Immunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.
Clin Gastroenterol Hepatol
; 13(7): 1293-1301.e5; quiz e70, e72, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724699
18.
Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease.
Gastroenterology
; 146(4): 941-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24361468
19.
Idiopathic Myointimal Hyperplasia of the Mesenteric Veins Diagnosed Preoperatively.
J Clin Gastroenterol
; 49(6): 491-4, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25626629
20.
Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
Gastroenterology
; 154(4): 1201-1202, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29432749